VAL-201

N/A

Report date: 2025/02/02 20:00:08
NME

Base Information

Drug NameVAL-201
Drug Alias NameVAL-201
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAndrogen Receptor antagonistsTyrosine-protein kinase SRC inhibitors
TargetsAndrogen ReceptorTyrosine-protein kinase SRC
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncolytika LtdBlack Cat Bio LtdTheoremRx Inc +[4] 
Active IndicationsN/A
Inactive IndicationsSolid tumoursProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A